Omega-3 fatty acids in major depressive disorder

Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

1997 • 7,096 citations

Psychopharmacology: The Fourth Generation of Progress

1995 • 2,920 citations

Cross-National Epidemiology of Major Depression and Bipolar Disorder

1996 • 2,176 citations

Psychopharmacology: The Fourth Generation of Progress

1995 • 1,676 citations

Distributed Disturbances in Brain Structure and Function in Schizophrenia

2000 • 964 citations

Omega 3 Fatty Acids in Bipolar Disorder

1999 • 815 citations

Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive Disorder

2002 • 627 citations

A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs

2002 • 618 citations

Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients

1998 • 580 citations

Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy

1995 • 532 citations

Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients

1998 • 480 citations

Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression

1996 • 474 citations

Cross-national epidemiology of major depression and bipolar disorder

1996 • 453 citations

Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients

1999 • 446 citations

Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

1996 • 426 citations

α‐Linolenic Acid Dietary Deficiency Alters Age‐Related Changes of Dopaminergic and Serotoninergic Neurotransmission in the Rat Frontal Cortex

1996 • 336 citations

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

2002 • 332 citations

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

2001 • 330 citations

A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia

2001 • 327 citations

Chronic Dietary α-Linolenic Acid Deficiency Alters Dopaminergic and Serotoninergic Neurotransmission in Rats ,

1994 • 318 citations

Randomized, Placebo-Controlled Study of Ethyl-Eicosapentaenoic Acid as Supplemental Treatment in Schizophrenia

2002 • 303 citations

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis Possible candidate genes

1999 • 222 citations

Do Lithium and Anticonvulsants Target the Brain Arachidonic Acid Cascade in Bipolar Disorder?

2002 • 194 citations

A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids

1998 • 156 citations

Polyunsaturated fatty acid deficit in patients with bipolar mania

2003 • 143 citations

Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient

2001 • 67 citations

Brain cortex phospholipids liposomes effects on CSF HVA, 5-HIAA and on prolactin and somatotropin secretion in man

1978 • 28 citations